98
Participants
Start Date
November 30, 2012
Primary Completion Date
May 31, 2015
Study Completion Date
March 31, 2021
BAROSTIM NEO® System
Implant procedure
Standard of care medical managment therapy for heart failure
Standard of care medical management therapy for heart failure (AHA/ACC guidelines), including drugs (determined by the patient's physician). Drug types include: Loop Diuretics, Thiazide Diuretics, Potassium-sparing Diuretics, Sequential Nephron Blockade, ACE Inhibitors, ARBs, ARNI, Aldosterone Antagonists, Beta Blockers and Hydralazine and Isosorbide Dinitrate.
Allegheny General Hospital, Pittsburgh
Drexel University College of Medicine, Philadelphia
George Washington University, Washington D.C.
Piedmont Heart Institute, Atlanta
AdventHealth Orlando, Orlando
ACRC - Cardiology, Atlantis
Tampa General Hospital, Tampa
University of Mississippi Medical Center, Jackson
The Ohio State University, Columbus
Mid-Michigan Medical Center Midland, Midland
Cardiac & Vascular Research Center of Northern Michigan, Petoskey
Wheaton Franciscan Healthcare, Milwaukee
Arizona Heart Rhythm Research Center, Phoenix
Aspirus Heart & Vascular Institute, Wausau
Advocate Medical Group, Naperville
Cardiovascular Institute of the South, Houma
Oklahoma Cardiovascular Research Group, Oklahoma City
Lonestar Heart Center, Amarillo
Southwest Cardiovascular Associates, Mesa
University Medical Center of Southern Nevada, Las Vegas
University of Southern California, Los Angeles
St Elizabeth's Medical Center, Brighton
Hackensack University Medical Center, Hackensack
Lead Sponsor
CVRx, Inc.
INDUSTRY